TDGF1 anticorps (AA 1-50)

N° du produit ABIN540265

Détail du produit anti-TDGF1 anticorps

Antigène: TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))

Épitope: AA 1-50

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TDGF1 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunocytochemistry (ICC)

Fonction: Rabbit polyclonal antibody raised against synthetic peptide of Tdgf1.

Specificité: This antibody is specific to cripto.

Réactivité croisée: Humain, Souris

Attributs du produit: Antibody Reactive Against Synthetic Peptide.

Immunogène: A synthetic peptide corresponding to amino acids 1-50 of mouse Tdgf1.

Information d'application

Indications d'application: Flow Cytometry (1:100)
Immunocytochemistry (1:50-1:200)
Immunofluorescence (1:50-1:200)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In Tris-glycine, 150 mM NaCl

Stock: 4 °C

Stockage commentaire: Store at 4°C. Do not freeze.

Références pour anticorps anti-TDGF1 (ABIN540265)

Xing, Hu, Pietersz, Hosick, McKenzie: "Cripto: a novel target for antibody-based cancer immunotherapy." dans: Cancer research, Vol. 64, Issue 11, pp. 4018-23, (2004) (PubMed).

Adamson, Minchiotti, Salomon: "Cripto: a tumor growth factor and more." dans: Journal of cellular physiology, Vol. 190, Issue 3, pp. 267-78, (2002) (PubMed).

Schiffer, Foley, Kaffashan, Hronowski, Zichittella, Yeo, Miatkowski, Adkins, Damon, Whitman, Salomon, Sanicola, Williams: "Fucosylation of Cripto is required for its ability to facilitate nodal signaling." dans: The Journal of biological chemistry, Vol. 276, Issue 41, pp. 37769-78, (2001) (PubMed).

Détails sur TDGF1

Antigène: TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))

Autre désignation: TDGF1 / CRIPTO (TDGF1 Produits)

ID gène: 21667

Pathways: EGFR Signaling Pathway